The sponge/Matrigel angiogenesis assay

Angiogenesis

Volumn 5, Issue 1-2, 2002, Pages 75-80

  Akhtar, Nasim ^a,b   Dickerson, Erin B ^b   Auerbach, Robert ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Angiogenesis; Assay; Endostatin; Matrigel; Vasculogenesis

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; ENDOSTATIN; FIBROBLAST GROWTH FACTOR 2; MATRIGEL;

ANALYTIC METHOD; ANGIOGENESIS; ANIMAL CELL; AORTA ARCH; ARTICLE; ASSAY; CHICK EMBRYO; DOG; DOSE TIME EFFECT RELATION; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; HOST CELL; IMAGE ANALYSIS; MATRIGEL PLUG ASSAY; MEDICAL DOCUMENTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; SOLID; SPONGE MATRIGEL ANGIOGENESIS ASSAY; STRAIN DIFFERENCE; STRAIN IDENTIFICATION;

ANGIOGENESIS INHIBITORS; ANIMALS; BIOLOGICAL ASSAY; COLLAGEN; DOGS; DRUG COMBINATIONS; ENDOSTATINS; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LAMININ; LYMPHOKINES; MICE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; PROTEOGLYCANS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; CANIS FAMILIARIS; MURINAE;

EID: 0038183641     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021507031486     Document Type: Article

References (27)

1. Auerbach R, Auerbach W, Polakowski I. Assays for angiogenesis. Pharmacol Ther 1991; 51: 1-11.
2. Auerbach W, Auerbach R. Angiogenesis inhibition: A review. Pharmacol Therap 1994; 63: 265-311.
3. Auerbach W, Auerbach R. In vivo assays for angiogenesis. In Maragoudakis ME et al. (eds): Angiogenesis: Molecular Biology, Clinical Aspects, New York: Plenum Press 1984; 283-7.
4. Auerbach R, Akhtar N, Lewis RL, Shinners BL. Angiogenesis assays: Problems and pitfalls. Cancer Metastasis Rev 2000; 19: 167-72.
5. Fan TP-D, Polverini PJ. In vivo models of angiogenesis. In Bicknell R, Ferrara N (eds): Tumor Angiogenesis. Oxford: Oxford University Press 1997; 5-18.
6. Jain RK, Schlenger K, Hoeckel M, Yuan F. Quantitative angiogenesis assays: Progress and problems. Nat Med 1997; 3: 1203-8.
7. Gimbrone MA Jr, Leapman SB, Cotran RS, Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 1974; 136: 261-76.
8. Muthukkaruppan VR, Auerbach R. Angiogenesis in the mouse cornea. Science 1979; 205: 1416-8.
9. Passaniti A, Taylor RM, Pili R et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin and fibroblast growth factor. Lab Invest 1992; 67: 519-28.
10. Grant DS, Kinsella JL, Fridman R et al. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J Cell Physiol 1992; 153: 614-25.
11. Thamm DH, Dickerson EB, Akhtar N et al. Biological and molecular characterization of a canine hemangiosarcoma cell line. Proceedings of the ACVIM 20th Annu Vet Med Forum, May 25-28, 2000. J Ver Intern Med 2000; 14: 123.
12. Thamm DH, Dickerson EB, Helfand SC, MacEwen EG. Expression of angiogenic growth factors and receptors in canine angiosarcoma. Proc Am Assoc Cancer Res (Abstr #3983). New Orleans, Louisiana, March 24-28, 2001.
13. Stewart RJ, Panigrahy D, Flynn E, Folkman J. Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: Evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts. J Urol 2001; 165: 688-93.
14. Obeso J, Weber J, Auerbach R. A hemangioendothelioma-derived cell line: Its use as a model for the study of endothelial cell biology. Lab Invest 1990; 63: 259-69.
15. Lin P, Buxton JA, Acheson A et al. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie-2. Proc Natl Acad Sci USA 1998; 95: 8829-34.
16. Rakhmilevich AL, Janssen K, Hao Z et al. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell independent mechanism. Cancer Gene Ther 2000; 7: 826-38.
17. Wang SJ, Greer P, Auerbach R. Isolation and propagation of yolk sac-derived endothelial cells from a hypervascular transgenic mouse expressing a gain-of-function fps/fes protooncogene. In Vitro Cell Dev Biol 1996; 32: 292-9.
18. Muthukkaruppan VR, Shinners BL, Lewis RL et al. The chick embryo aortic arch assay: A new, rapid, quantifiable in vitro method for testing the efficacy of angiogenic and anti-angiogenic factors in a three-dimensional, serum-free organ culture system. Proc AACR Annual Meeting, April, 2000.
19. Rohan RM, Fernandez A, Udagawa T, Yuan J. D'Amato RJ. Genetic heterogeneity of angiogenesis in mice. FASEB J 2000; 14: 871-6.
20. Kenyon BM, Voest EE, Chen C et al. A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 1996; 37: 1625-32.
21. Cao Z, Baguley BC, Ching L-M. Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthrenon-4 acetic acid (DMXAA). Cancer Res 2001; 61: 1517-21.
22. Sweeney CJ, Miller KD, Sissons SE et al. The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors. Cancer Res 2001; 61: 3369-72.
23. Baish JW, Jain RK. Fractals and Cancer. Cancer Res 2000; 60: 3683-8.
24. Dellian M, Witwer BP, Salehi HA et al. Quantitation and physiological characterization of angiogenic vessels in mice. Effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor and host microenvironment. Am J Pathol 1996; 149: 59-71.
25. Parsons-Wingerter P, Lwai B, Yang MC et al. A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. Microvasc Res 1998; 55: 201-14.
26. Sidky YA, Auerbach R. Lymphocyte-induced angiogenesis: A quantitative and sensitive assay of the graft-vs.-host reaction. J Exp Med 1975; 141: 1084-1100.
27. Kumar CC, Malkowski M, Yin Z et al. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist. Cancer Res 2001; 61: 2232-8.